On October 16, 2026, 10x Genomics Inc (TXG) shares fell 3.5%, bringing the current price to $69.86.

PLEASANTON, Calif., Oct. 13, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science

TD Cowen analyst Dan Brennan maintains 10x Genomics (NASDAQ:TXG) with a Hold and raises the price

Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Equal-Weight and r

Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises t

Forget the "Magnificent Seven" in favor of the "Tremendous Three"?

U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaf

Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises th

10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science

Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia,

Entegris, Rocket and KLA led premarket gains after September payrolls rose just 29,000 vs. 90,000 ex

Leerink Partners analyst Mike Kratky maintains 10x Genomics (NASDAQ:TXG) with a Market Perform an

 Atera is moving into the hands of researchers around the world, from those scaling existing spatial

Sentira Spatial Analysis leverages NVIDIA accelerated computing to cut spatial data processing times

Piper Sandler analyst David Westenberg maintains 10x Genomics (NASDAQ:TXG) with a Neutral and rai

Analysts initiate coverage: Buy on IonQ ($60), Jack Henry ($193) and 10X Genomics ($110); Overweight

Argus Research analyst John Eade initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy ratin

Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs t

U.S. stocks fell, but Radiant Logistics surged 17.8% after beating Q4 estimates. Waystar, Telix and

Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today a

UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price t

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the fu

RBC Capital analyst Dan Leonard initiates coverage on 10x Genomics (NASDAQ:TXG) with a Sector Per

10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Bioscien

Jury finds Parse willfully infringed Scale Biosciences' patents and rejects Parse's invalidi

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting str

Stephens & Co. analyst Mason Carrico maintains 10x Genomics (NASDAQ:TXG) with a Overweight an

Piper Sandler analyst David Westenberg maintains 10x Genomics (NASDAQ:TXG) with a Neutral and rai

Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises t

Citigroup analyst Brendan Digan maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the

Morgan Stanley analyst Tejas Savant maintains 10x Genomics (NASDAQ:TXG) with a Equal-Weight and r

10x Genomics (NASDAQ:TXG) raises FY2026 sales outlook from $600.000 million-$625.000 million to $610

10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.14) per share which beat the analyst cons

This collaboration builds on 10x's broader efforts to work with leading research institutions to

Tema's new Healthcare AI ETF (HLTH), targets AI-powered drug discovery, diagnostics, robotics an

Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia He

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Gold fell 9.5% and silver collapsed 27%, sparking a mining stock bloodbath as markets repriced Fed r

Ark Invest, led by Cathie Wood, issued another "Big Ideas" list on Wednesday, sharing themes

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potenti